Michael is a Partner at Baird Capital in London, specializing in Technology & Services investments. A Chartered Accountant with a First Class Masters in Chemistry from the University of Bristol, he executes global M&A deals and serves on multiple company boards. Colleagues praise his strong industry-specific knowledge and technical ability.
His background in chemistry and early career in the pharmaceutical sector with GSK provide a strong foundation for his professional focus on technology and healthcare. This scientific grounding complements his five years of experience in M&A, financial due diligence, and corporate finance before joining the world of private equity.
He co-authored a scientific paper on a novel method for synthesizing nanocomposite tungsten carbide-cobalt using a biopolymer as a carbon source.
Read the full overview →They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to do thorough analysis of any situation.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.